These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1710410)

  • 41. Disappearance of factor VIII autoantibodies preceding autoimmune haemolytic anaemia.
    van den Brink EN; Turenhout EA; Wijn-Maas EC; van der Meer FJ; Voorberg J; Bosch LJ
    Haemophilia; 2000 Nov; 6(6):698-701. PubMed ID: 11122400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunocoagulopathies as a possible cause of acquired hemorrhagic diathesis].
    Klare M; Möller T; Hanke P; Weller P; Seige K
    Z Gesamte Inn Med; 1983 May; 38(10):277-80. PubMed ID: 6412468
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunochemical characterization of antibodies to factor VIII in hemophilic and nonhemophilic patients.
    Allain JP; Gaillandre A; Lee H
    J Lab Clin Med; 1981 Jun; 97(6):791-800. PubMed ID: 6785371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.
    Towfighi F; Gharagozlou S; Sharifian RA; Kazemnejad A; Esmailzadeh K; Managhchi MR; Shokri F
    Acta Haematol; 2005; 114(2):84-90. PubMed ID: 16103630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Atypical spontaneous factor VIII inhibitor: specific diagnostics and therapy of acute bleeding.
    Steinbrueckner B; Steigerwald U; Keller F; Ordung R; Neuenroth L; Reuther J; Klinker H; Schwender S
    Acta Haematol; 1998; 99(2):102-5. PubMed ID: 9554460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A factor VIII neutralizing monoclonal antibody and a human inhibitor alloantibody recognizing epitopes in the C2 domain inhibit factor VIII binding to von Willebrand factor and to phosphatidylserine.
    Shima M; Scandella D; Yoshioka A; Nakai H; Tanaka I; Kamisue S; Terada S; Fukui H
    Thromb Haemost; 1993 Mar; 69(3):240-6. PubMed ID: 7682339
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cyclosporin treatment of a woman with acquired haemophilia due to factor VIII:C inhibitor.
    Pfliegler G; Boda Z; Hársfalvi J; Flóra-Nagy M; Sári B; Pecze K; Rak K
    Postgrad Med J; 1989 Jun; 65(764):400-2. PubMed ID: 2514421
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acquired hemophilia: a case report of 2 patients with acquired factor VIII inhibitor treated with rituximab plus a short course of steroid and review of the literature.
    Alvarado Y; Yao X; Jumper C; Hardwicke F; D'Cunha N; Cobos E
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):443-8. PubMed ID: 17911199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful treatment of acquired factor VIII antibody by extracorporeal immunoadsorption.
    Négrier C; Dechavanne M; Alfonsi F; Tremisi PJ
    Acta Haematol; 1991; 85(2):107-10. PubMed ID: 1902613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Massive bleeding episodes in patients with acquired haemophilia--case report].
    Sokołowska B; Tomczak W; Gromek T; Legieć W
    Pol Arch Med Wewn; 2006 Apr; 115(4):351-5. PubMed ID: 17078494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acquired hemophilia.
    Bouvry P; Recloux P
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies.
    Green D; Rademaker AW; Briët E
    Thromb Haemost; 1993 Nov; 70(5):753-7. PubMed ID: 8128430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acquired factor VIII inhibitor.
    Simpson WG; Neefe J; Zang J; Drosick R; Kearns R
    J Ky Med Assoc; 1991 Nov; 89(11):555-7. PubMed ID: 1748831
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acquired hemophilia: a case report.
    Flisiński M; Windyga J; Stefańska E; Huszcza S; Donderski R; Manitius J
    Pol Arch Med Wewn; 2008 Apr; 118(4):228-33. PubMed ID: 18575423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Identification of IgG subclass and FVIII binding epitope of an acquired FVIII inhibitor in a bullous pemphigoid patient].
    Zuo WL; Zhang GS; Qing ZJ; Xu YX; Qin LX; Xu M
    Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):593-7. PubMed ID: 17278424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disappearance of antibodies to Factor VIII in a patient with acquired haemophilia and carcinoma of the pancreas during cytotoxic therapy with fluorouracil and CCNU.
    Rhodes EG; Boesen EA; Corringham RE; Matthews KB; Tuddenham EG; Kernoff PB
    Thromb Haemost; 1984 Oct; 52(2):131-3. PubMed ID: 6084319
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cholecystectomy and acquired factor VIII inhibitor coagulopathy.
    Walsh JD; Landercasper J; Bottner WA; Boyd WC
    Am Surg; 2004 Sep; 70(9):815-7. PubMed ID: 15481301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection and typing of serum paraproteins with the Quantimetric kappa:Lambda ratio test.
    Guinan JE; Kenny DF; Gatenby PA
    Clin Chem; 1986 Oct; 32(10):1981-2. PubMed ID: 3093122
    [No Abstract]   [Full Text] [Related]  

  • 59. [Determination of factor VIII-coagulation antigen in factor VIII concentrates using an inhibitor test].
    Im T; Hintz G
    Arzneimittelforschung; 1986; 36(1):124-6. PubMed ID: 3082340
    [TBL] [Abstract][Full Text] [Related]  

  • 60. IgGs containing λ- and κ-type light chains and of all subclasses (IgG1-IgG4) from the sera of patients with autoimmune diseases and viral and bacterial infections hydrolyze DNA.
    Parkhomenko TA; Buneva VN; Doronin BM; Volkova MV; Senkovich SA; Generalov II; Nevinsky GA
    J Mol Recognit; 2012 Jul; 25(7):383-92. PubMed ID: 22733547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.